Original Article
Phenotyping and follow up of forty-seven Iranian patients with common variable immunodeficiency
Saba Arshia, Mohammad Nabavia, Mohammad Hasan Bemaniana, Ramin Shakerib, Behrang Taghvaeia, Babak Ghalebaghia,c, Delara Babaied, Ahmad Bahramia, Morteza Fallahpoura, Hossein Esmaeilzadehe, Mahsa Rekabia, Javad Amadiana, Narjes Eslamia, Sima Shokria, Farhad Jalalia, Nadieh Akbarpoura, Rasol Molatefia,
, Nima Rezaeif,g,h
Corresponding author
a Allergy and Clinical Immunology Department of Rasol-E-Akram Hospital, Iran University of Medical Sciences (IUMS), Tehran, Iran
b Digestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences (TUMS), Tehran, Iran
c Research Center of Otolaryngology and Head & Neck Surgery, IUMS, Tehran, Iran
d Allergy and Clinical Immunology Department of Mofid Hospital, Shaheed Beheshti University of Medical Sciences (SBMU), Tehran, Iran
e Allergy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
f Molecular Immunology Research Center and Department of Immunology, School of Medicine, Tehran University of Medical Sciences (TUMS), Tehran, Iran
g Research Center for Immunodeficiency, Children's Medical Center, TUMS, Tehran, Iran
h Universal Scientific Education and Research Network (USERN), Tehran, Iran
Read
2301
Timeswas read the article
754
Total PDF
1547
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 24 | 10 | 34 |
| 2025 11 | 55 | 14 | 69 |
| 2025 10 | 46 | 13 | 59 |
| 2025 9 | 39 | 14 | 53 |
| 2025 8 | 47 | 20 | 67 |
| 2025 7 | 42 | 11 | 53 |
| 2025 6 | 25 | 5 | 30 |
| 2025 5 | 46 | 3 | 49 |
| 2025 4 | 28 | 5 | 33 |
| 2025 3 | 32 | 2 | 34 |
| 2025 2 | 42 | 7 | 49 |
| 2025 1 | 29 | 15 | 44 |
| 2024 12 | 13 | 4 | 17 |
| 2024 11 | 18 | 5 | 23 |
| 2024 10 | 13 | 3 | 16 |
| 2024 9 | 19 | 5 | 24 |
| 2024 8 | 21 | 5 | 26 |
| 2024 7 | 23 | 6 | 29 |
| 2024 6 | 17 | 3 | 20 |
| 2024 5 | 17 | 9 | 26 |
| 2024 4 | 23 | 7 | 30 |
| 2024 3 | 14 | 1 | 15 |
| 2024 2 | 14 | 3 | 17 |
| 2024 1 | 14 | 5 | 19 |
| 2023 12 | 29 | 7 | 36 |
| 2023 11 | 31 | 11 | 42 |
| 2023 10 | 20 | 8 | 28 |
| 2023 9 | 11 | 0 | 11 |
| 2023 8 | 13 | 5 | 18 |
| 2023 7 | 25 | 8 | 33 |
| 2023 6 | 16 | 1 | 17 |
| 2023 5 | 35 | 5 | 40 |
| 2023 4 | 32 | 4 | 36 |
| 2023 3 | 36 | 2 | 38 |
| 2023 2 | 22 | 4 | 26 |
| 2023 1 | 23 | 13 | 36 |
| 2022 12 | 28 | 9 | 37 |
| 2022 11 | 16 | 11 | 27 |
| 2022 10 | 17 | 15 | 32 |
| 2022 9 | 17 | 11 | 28 |
| 2022 8 | 16 | 8 | 24 |
| 2022 7 | 12 | 11 | 23 |
| 2022 6 | 17 | 7 | 24 |
| 2022 5 | 23 | 14 | 37 |
| 2022 4 | 21 | 16 | 37 |
| 2022 3 | 15 | 6 | 21 |
| 2022 2 | 12 | 4 | 16 |
| 2022 1 | 19 | 12 | 31 |
| 2021 12 | 13 | 7 | 20 |
| 2021 11 | 14 | 13 | 27 |
| 2021 10 | 18 | 15 | 33 |
| 2021 9 | 18 | 15 | 33 |
| 2021 8 | 11 | 6 | 17 |
| 2021 7 | 13 | 15 | 28 |
| 2021 6 | 15 | 8 | 23 |
| 2021 5 | 18 | 10 | 28 |
| 2021 4 | 74 | 34 | 108 |
| 2021 3 | 45 | 18 | 63 |
| 2021 2 | 16 | 9 | 25 |
| 2021 1 | 18 | 11 | 29 |
| 2020 12 | 0 | 1 | 1 |
| 2020 11 | 0 | 2 | 2 |
| 2020 8 | 0 | 2 | 2 |
| 2020 7 | 0 | 4 | 4 |
| 2020 5 | 0 | 1 | 1 |
| 2020 3 | 0 | 4 | 4 |
| 2020 2 | 0 | 1 | 1 |
| 2019 12 | 0 | 3 | 3 |
| 2019 11 | 0 | 1 | 1 |
| 2019 10 | 0 | 2 | 2 |
| 2019 9 | 0 | 1 | 1 |
| 2019 7 | 0 | 1 | 1 |
| 2019 6 | 0 | 6 | 6 |
| 2018 3 | 1 | 1 | 2 |
| 2018 2 | 5 | 4 | 9 |
| 2018 1 | 6 | 3 | 9 |
| 2017 12 | 3 | 3 | 6 |
| 2017 11 | 17 | 7 | 24 |
| 2017 10 | 7 | 3 | 10 |
| 2017 9 | 6 | 11 | 17 |
| 2017 8 | 4 | 7 | 11 |
| 2017 7 | 2 | 3 | 5 |
| 2017 6 | 5 | 16 | 21 |
| 2017 5 | 9 | 23 | 32 |
| 2017 4 | 4 | 16 | 20 |
| 2017 3 | 31 | 47 | 78 |
| 2017 2 | 4 | 10 | 14 |
| 2017 1 | 0 | 8 | 8 |
| 2016 12 | 0 | 10 | 10 |
| 2016 11 | 0 | 6 | 6 |
| 2016 10 | 0 | 6 | 6 |
| 2016 9 | 0 | 3 | 3 |
| 2016 8 | 0 | 4 | 4 |
| 2016 7 | 0 | 3 | 3 |
| 2016 6 | 0 | 1 | 1 |
| 2016 5 | 3 | 2 | 5 |
Show all
